Literature DB >> 28843244

In Vitro Leukoagglutination: A Rare Hematological Cause of Spurious Leukopenia.

Sadia Sultan1, Syed Muhammad Irfan1.   

Abstract

Leukopenia secondary to leukocytic agglutination is caused by an ethylene diamine tetra acetic acid (EDTA) which may appear in both benign and malignant states. Ethylene diamine tetra acetic acid induced platelets clumping in peripheral blood has been well established, but invitro leukocytic aggregation is very rarest hematological finding. Pseudo-leukopenia resulting from leukoagglutinins has been reported in the cirrhotic state, infections, autoimmune disorders, uremia, in immunosuppressed state or in various malignancies. Though the condition seems to be benign but very important to be detected as these artifactual findings lead to unnecessary investigations and remarkably changed the overall management plan. Here we report the case of a young patient with this rare finding who was admitted to our hospital with progressive labor pains. The analysis of ethylene diaminetetraacetic acid (EDTA), anticoagulated blood was done on automated hematology analyzer reveals leukopenia. The peripheral smear examination revealed multiple aggregates of leukocytes. On repeat sampling in citrate anticoagulant, the complete blood count showed total leukocytic count of 16.5x109/L with absolute neutrophilic count of 11.5x109/L. This is a rare case of spurious leukopenia secondary to in-vitro leukocytic agglutination provoked by EDTA anticoagulant.

Entities:  

Keywords:  Ethylenediaminetetraacetic acid; Leukoagglutinins; Leukopenia

Mesh:

Substances:

Year:  2017        PMID: 28843244

Source DB:  PubMed          Journal:  Acta Med Iran        ISSN: 0044-6025


  2 in total

Review 1.  Unreliable Automated Complete Blood Count Results: Causes, Recognition, and Resolution.

Authors:  Gene Gulati; Guldeep Uppal; Jerald Gong
Journal:  Ann Lab Med       Date:  2022-09-01       Impact factor: 4.941

2.  Unusual leukoagglutination: A rare haematological finding.

Authors:  Massimo Daves; Vincenzo Roccaforte; Erika Jani; Evi Peer
Journal:  Hematol Transfus Cell Ther       Date:  2020-12-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.